Abstract:Induction of pluripotent stem cells from somatic cells by defined factors was shown to be possible only recently, but already several laboratories have made tremendous strive toward improving and understanding the process. Originally, Oct4, Sox2, Klf4, and cMyc were identified as being the combination of genes necessary to induce reprogramming. It was later shown that cMyc was dispensable; however, in its absence the process was less efficient and took a considerably longer period of time to occur. Furthermore, others have shown that the combination of Oct4, Sox2, Nanog, and Lin28 could also induce reprogramming. One major caveat associated with these techniques remains the need for overexpression of several genes using viral systems. Until very recently, most studies were done using integrating viruses such as retroviruses and lentiviruses. This method ensured that the protein of interested would be expressed at a high concentration and for an adequate period of time necessary to induce reprogramming. Up to date, others have now been able to use different nonintegrative method such as adenovirus and plasmid transfection to induce reprogramming. Furthermore, piggyBac transposition was successfully used to induce reprogramming of murine cells. Most importantly, it was recently published that reprogramming can be induced in the absence of virus, with proteins and small molecules. All of the later methods are appealing since they do not require the integration of the virus or plasmid to exert its effect. However, one avenue that would be all the more therapeutically appealing would be to induce reprogramming in the absence of gene overexpression systems, using small molecules to modulate signaling pathways in the somatic cells. A few molecules have already been identified with the ability to either improve the process or replace one or two of the genes deemed necessary for reprogramming. We have screened successfully for compounds that can replace some of these factors, and share the methods developed following these screens.

Evaluation of the determinants for improved pluripotency induction and maintenance by engineered SOX17

Conversion of Sox17 into A Pluripotency Reprogramming Factor by Reengineering Its Association with Oct4 on Dna

Sox Transcription Factors Require Selective Interactions with Oct4 and Specific Transactivation Functions to Mediate Reprogramming

Highly cooperative chimeric super-SOX induces naive pluripotency across species

Harnessing Endogenous Transcription Factors Directly by Small Molecules for Chemically Induced Pluripotency Inception.

Multifaceted SOX2-chromatin interaction underpins pluripotency progression in early embryos

Site-Specific Disruption of the Oct4/Sox2 Protein Interaction Reveals Coordinated Mesendodermal Differentiation and the Epithelial-Mesenchymal Transition

Pluripotency Reprogramming by Competent and Incompetent POU Factors Uncovers Temporal Dependency for Oct4 and Sox2.

Cellular Context- and Protein Level-Dependent Interaction of Pluripotency Factor OCT4A with Multiple Octamer Motifs of the Same Target Gene

Sox2 and Klf4 as the Functional Core in Pluripotency Induction without Exogenous Oct4.

Fine-tuning of iPSC derivation by an inducible reprogramming system at the protein level.

Induction of Pluripotent Stem Cells from Mouse Embryonic Fibroblasts by Oct4 and Klf4 with Small-Molecule Compounds

Oct4 Switches Partnering from Sox2 to Sox17 to Reinterpret the Enhancer Code and Specify Endoderm

The Nuclear Receptor Nr5a2 Can Replace Oct4 in the Reprogramming of Murine Somatic Cells to Pluripotent Cells

Enhancer-promoter association determines Sox2 transcription regulation in mouse pluripotent cells

Transcriptional Regulation of Nanog by OCT4 and SOX2

Induction of Pluripotency in Mouse Somatic Cells with Lineage Specifiers

Sox2, a Key Factor in the Regulation of Pluripotency and Neural Differentiation

Reciprocal Transcriptional Regulation of Pou5f1 and Sox2 via the Oct4/Sox2 Complex in Embryonic Stem Cells

Phosphorylation of Sox2 Cooperates in Reprogramming to Pluripotent Stem Cells

Using Small Molecules to Improve Generation of Induced Pluripotent Stem Cells from Somatic Cells